Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2014, Article ID 926875, 10 pages
http://dx.doi.org/10.1155/2014/926875
Research Article

IL-27 Activates Human Trophoblasts to Express IP-10 and IL-6: Implications in the Immunopathophysiology of Preeclampsia

1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China
2Laboratory of Lipid & Glucose Research, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China

Received 29 October 2013; Accepted 25 December 2013; Published 10 February 2014

Academic Editor: Eric F. Morand

Copyright © 2014 Nanlin Yin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Willis, J. M. Morris, V. Danis, and E. D. M. Gallery, “Cytokine production by peripheral blood monocytes during the normal human ovulatory menstrual cycle,” Human Reproduction, vol. 18, no. 6, pp. 1173–1178, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. C. W. G. Redman, G. P. Sacks, and I. L. Sargent, “Preeclampsia: an excessive maternal inflammatory response to pregnancy,” American Journal of Obstetrics & Gynecology, vol. 180, no. 2, pp. 499–506, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Molvarec, A. Szarka, S. Walentin, E. Szucs, B. Nagy, and J. Rigó Jr., “Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia,” Hypertension Research, vol. 33, no. 9, pp. 892–898, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Szarka, J. Rigó Jr., L. Lázár, G. Beko, and A. Molvarec, “Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array,” BMC Immunology, vol. 11, article 59, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. B. D. LaMarca, M. J. Ryan, J. S. Gilbert, S. R. Murphy, and J. P. Granger, “Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia,” Current Hypertension Reports, vol. 9, no. 6, pp. 480–485, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Lotz, “Interleukin-6: a comprehensive review,” Cancer Treatment and Research, vol. 80, pp. 209–233, 1995. View at Publisher · View at Google Scholar · View at Scopus
  7. J. P. Xiao, Y. X. Yi, Y. F. Gao et al., “The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia,” Cytokine, vol. 60, no. 3, pp. 856–860, 2012. View at Publisher · View at Google Scholar
  8. M. L. Liu, S. C. Guo, J. M. Hibbert et al., “CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications,” Cytokine & Growth Factor Reviews, vol. 22, no. 3, pp. 121–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Gotsch, R. Romero, L. Friel et al., “CXCL10/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?” Journal of Maternal-Fetal and Neonatal Medicine, vol. 20, no. 11, pp. 777–792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Molvarec, A. Szarka, S. Walentin et al., “Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia,” Reproductive Biology and Endocrinology, vol. 9, article 124, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Pflanz, J. C. Timans, J. Cheung et al., “IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells,” Immunity, vol. 16, no. 6, pp. 779–790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Pflanz, L. Hibbert, J. Mattson et al., “WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27,” The Journal of Immunology, vol. 172, no. 4, pp. 2225–2231, 2004. View at Google Scholar · View at Scopus
  13. H. Yoshida, M. Nakaya, and Y. Miyazaki, “Interleukin 27: a double-edged sword for offense and defense,” Journal of Leukocyte Biology, vol. 86, no. 6, pp. 1295–1303, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Q. Chen, N. Ghilardi, H. Wang et al., “Development of Th1-type immune responses requires the type I cytokine receptor TCCR,” Nature, vol. 407, no. 6806, pp. 916–920, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. A. V. Villarino, E. Huang, and C. A. Hunter, “Understanding the pro- and anti-inflammatory properties of IL-27,” The Journal of Immunology, vol. 173, no. 2, pp. 715–720, 2004. View at Google Scholar · View at Scopus
  16. M. B. Pinheiro, O. A. Martins-Filho, A. P. Mota et al., “Severe preeclampsia goes along with a cytokine network disturbance towards a systemic inflammatory state,” Cytokine, vol. 62, no. 1, pp. 165–173, 2013. View at Publisher · View at Google Scholar
  17. C. J. Lockwood, C.-F. Yen, M. Basar et al., “Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells,” The American Journal of Pathology, vol. 172, no. 6, pp. 1571–1579, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Kontic-Vucinic, M. Terzic, and N. Radunovic, “The role of antioxidant vitamins in hypertensive disorders of pregnancy,” Journal of Perinatal Medicine, vol. 36, no. 4, pp. 282–290, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Belperio, M. P. Keane, D. A. Arenberg et al., “CXC chemokines in angiogenesis,” Journal of Leukocyte Biology, vol. 68, no. 1, pp. 1–8, 2000. View at Google Scholar · View at Scopus
  20. G. Bernardini, D. Ribatti, G. Spinetti et al., “Analysis of the role of chemokines in angiogenesis,” Journal of Immunological Methods, vol. 273, no. 1-2, pp. 83–101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. M. Rosenkilde and T. W. Schwartz, “The chemokine system—a major regulator of angiogenesis in health and disease,” APMIS, vol. 112, no. 7-8, pp. 481–495, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Strieter, M. D. Burdick, B. N. Gomperts, J. A. Belperio, and M. P. Keane, “CXC chemokines in angiogenesis,” Cytokine & Growth Factor Reviews, vol. 16, no. 6, pp. 593–609, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Nagaoka, H. Nojima, F. Watanabe et al., “Regulation of blastocyst migration, apposition, and initial adhesion by a chemokine, interferon γ-inducible protein 10 kDa (IP-10), during early gestation,” The Journal of Biological Chemistry, vol. 278, no. 31, pp. 29048–29056, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Hanna, D. Goldman-Wohl, Y. Hamani et al., “Decidual NK cells regulate key developmental processes at the human fetal-maternal interface,” Nature Medicine, vol. 12, no. 9, pp. 1065–1074, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. M. Borzychowski, I. L. Sargent, and C. W. G. Redman, “Inflammation and pre-eclampsia,” Seminars in Fetal and Neonatal Medicine, vol. 11, no. 5, pp. 309–316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Wang and S. W. Walsh, “TNFα concentrations and mRNA expression are increased in preeclamptic placentas,” Journal of Reproductive Immunology, vol. 32, no. 2, pp. 157–169, 1996. View at Publisher · View at Google Scholar · View at Scopus
  27. I. Beckmann, S. B. Efraim, M. Vervoort, W. Visser, and H. C. S. Wallenburg, “Tumor necrosis factor-α in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women,” Hypertension in Pregnancy, vol. 23, no. 3, pp. 319–329, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. B. B. D. LaMarca, K. Cockrell, E. Sullivan, W. Bennett, and J. P. Granger, “Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats,” Hypertension, vol. 46, no. 1, pp. 82–86, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Xu, S. Nakhla, A. Makris, and A. Hennessy, “TNF-α inhibits trophoblast integration into endothelial cellular networks,” Placenta, vol. 32, no. 3, pp. 241–246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Shibata, Y. Tada, N. Kanda et al., “Possible roles of IL-27 in the pathogenesis of psoriasis,” Journal of Investigative Dermatology, vol. 130, no. 4, pp. 1034–1039, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Cao, P. D. Doodes, T. T. Glant, and A. Finnegan, “IL-27 induces a Th1 immune response and susceptibility to experimental arthritis,” The Journal of Immunology, vol. 180, no. 2, pp. 922–930, 2008. View at Google Scholar · View at Scopus
  32. S. Dong, X. Zhang, Y. He et al., “Synergy of IL-27 and TNF-α in regulating CXCL10 expression in lung fibroblasts: implications in airway inflammation,” American Journal of Respiratory Cell and Molecular Biology, vol. 48, no. 4, pp. 518–530, 2013. View at Publisher · View at Google Scholar
  33. R. Goldberg, G. Wildbaum, Y. Zohar, G. Maor, and N. Karin, “Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27,” The Journal of Immunology, vol. 173, no. 2, pp. 1171–1178, 2004. View at Google Scholar · View at Scopus
  34. M. C. Genovese, J. D. McKay, E. L. Nasonov et al., “Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study,” Arthritis & Rheumatism, vol. 58, no. 10, pp. 2968–2980, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Puppo, G. Murdaca, M. Ghio, and F. Indiveri, “Emerging biologic drugs for the treatment of rheumatoid arthritis,” Autoimmunity Reviews, vol. 4, no. 8, pp. 537–541, 2005. View at Publisher · View at Google Scholar · View at Scopus